Neuralink has received the green light to initiate recruitment for its inaugural human clinical trial, dubbed the PRIME Study (Precise Robotically Implanted Brain-Computer Interface).
A study published in the Journal of Exposure Science and Environmental Epidemiology found that women with higher levels of forever chemicals had a greater risk of developing breast, ovary, skin, and uterus cancer.
U.S. gov't has "used taxpayer dollars to pressure large social media platforms into moderating online discourse on topics like COVID-19 vaccines and the use of masks."
